Wrong party, wrong court: Moderna fights back against patent infringement case surrounding its Covid-19 vaccine
Arbutus and Genevant filed a lawsuit back in February accusing Moderna of stealing the former’s patented lipid nanoparticle technology for its Covid-19 vaccine. On Friday, Moderna put its hands up, claiming that the plaintiffs are suing the wrong party in the wrong court.
Moderna requested a dismissal on Friday, arguing that Arbutus and Genevant should really be suing the federal government, as the vaccine was supplied to the feds through a contract as part of the country’s emergency response efforts.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.